Dutch Diabetes Care Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Device ((Blood Glucose Monitoring Systems (Self-monitoring Blood Glucose Monitoring Systems, Continuous Glucose Monitoring systems, Test strips/Test Papers and Lancets/Lancing Devices), Insulin Delivery Devices (Insulin Pumps, Insulin Pens, Insulin Syringes and Needles and Others), By End-user (Hospitals, Specialty Clinics and Home Care), and Country Forecast 2020-2031

Dutch Diabetes Care Devices Market size was valued at US$ 52,169.9 million in 2024 and is expected to reach US$ 1,03,621.2 million by 2031, growing at a significant CAGR of 10.3% from 2025-2031. The medical devices for the care of diabetes are aimed at assisting people who are suffering from the disease. Equipment ranges from blood glucose monitoring devices to insulin delivery devices and other products that make the management of diabetes easy. Generally, such devices aim to assist patients in maintaining appropriate glucose levels, avoiding complications, and enhancing the quality of life.

The Dutch Diabetes Care Devices Market is well-established and growing in the Netherlands healthcare industry. Such a market would comprise a range of products, including glucose meters, insulin pumps, continuous glucose monitoring systems, insulin pens, and their accessories. In addition, infrastructural strength of the healthcare system with a growing pool of diabetic patients and the emergence of new technologies in medical treatment would favor the market. The number of diabetes cases in the Netherlands is rising, driving the demand for diabetes care devices. This increase is largely due to aging populations, sedentary lifestyles, and dietary habits. For instance, in the Netherlands, the current approximated national prevalence of diabetes mellitus at all ages is 6.9%, with an estimated number of 1.2 million patients, a number expected to rise to 1.4 million by 2040.  

Additionally, continuous innovations in diabetes management technologies, such as advanced CGM systems and smart insulin pens, are pushing market growth. Whereas, the cost of acquiring and maintaining advanced devices like insulin pumps and CGMs can be a barrier, particularly for uninsured individuals. However, the integration of diabetes care devices with digital health platforms offers opportunities for more personalized and efficient diabetes management.

Key Developments

• In 2023 - Roche Introduces the Accu-Chek® Guide System. Roche, one of the diabetes care leaders, has launched the Accu-Chek® Guide system in the Dutch market. Using this system, diabetic patients will be able to measure blood glucose more conveniently than with previously available devices.
• 2022-Abbott FreeStyle Libre 3 Approved. Abbott received an approval for FreeStyle Libre 3, its CGM system, in the Netherlands. That is a system performing real-time glucose readings and highly valued because of its tiny size and high accuracy.
• 2021 - MiniMed™ 780G System. Medtronic, the global leader in diabetes care technologies, announces the Netherlands introduction of the MiniMed™ 780G System.